StockData
BioVie Inc. logo

BioVie Inc. (BIVI) stock

BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.00−0.08 (-7.84%)

Close on Nov 17, 2026Market cap $7.51MP/E –Yield –

BioVie total assets

Total assets on the balance sheet at the end of each period.

BioVie's total assets was $14.25M at Jun 30, 2026. For fiscal 2026 it was $14.25M, down 33.9% from the year before. Over ten years it grew 18.0% a year on average. The highest annual figure on record is $35.10M in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026$14.25M-33.9%
FY2025Jun 30, 2025$21.56M-14.5%
FY2024Jun 30, 2024$25.21M-28.2%
FY2023Jun 30, 2023$35.10M+74.5%
FY2022Jun 30, 2022$20.11M+232.7%
FY2021Jun 30, 2021$6.05M+190.2%
FY2020Jun 30, 2020$2.08M-19.1%
FY2019Jun 30, 2019$2.57M+18.3%
FY2018Jun 30, 2018$2.18M-8.0%
FY2017Jun 30, 2017$2.36M-13.1%
FY2016Jun 30, 2016$2.72M+909.0%
FY2015Jun 30, 2015$269.48K-19.0%
FY2014Jun 30, 2014$332.86K-34.2%
FY2013Jun 30, 2013$505.70K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$14.25M-33.9%
Q3 FY2026CQ1 2026Mar 31, 2026$17.51M-29.0%
Q2 FY2026CQ4 2025Dec 31, 2025$22.50M-12.4%
Q1 FY2026CQ3 2025Sep 30, 2025$26.82M+26.3%
Q4 FY2025CQ2 2025Jun 30, 2025$21.56M-14.5%
Q3 FY2025CQ1 2025Mar 31, 2025$24.66M-22.4%
Q2 FY2025CQ4 2024Dec 31, 2024$25.69M+19.6%
Q1 FY2025CQ3 2024Sep 30, 2024$21.24M-10.6%
Q4 FY2024CQ2 2024Jun 30, 2024$25.21M-28.2%
Q3 FY2024CQ1 2024Mar 31, 2024$31.77M-29.7%
Q2 FY2024CQ4 2023Dec 31, 2023$21.49M-54.5%
Q1 FY2024CQ3 2023Sep 30, 2023$23.76M+3.9%
Q4 FY2023CQ2 2023Jun 30, 2023$35.10M+74.5%
Q3 FY2023CQ1 2023Mar 31, 2023$45.18M+72.5%
Q2 FY2023CQ4 2022Dec 31, 2022$47.19M+48.1%
Q1 FY2023CQ3 2022Sep 30, 2022$22.86M+4.0%
Q4 FY2022CQ2 2022Jun 30, 2022$20.11M+232.7%
Q3 FY2022CQ1 2022Mar 31, 2022$26.19M+103.1%
Q2 FY2022CQ4 2021Dec 31, 2021$31.87M+136.8%
Q1 FY2022CQ3 2021Sep 30, 2021$21.98M+47.9%
Q4 FY2021CQ2 2021Jun 30, 2021$6.05M+190.2%
Q3 FY2021CQ1 2021Mar 31, 2021$12.89M+458.3%
Q2 FY2021CQ4 2020Dec 31, 2020$13.46M+475.3%
Q1 FY2021CQ3 2020Sep 30, 2020$14.86M+469.8%
Q4 FY2020CQ2 2020Jun 30, 2020$2.08M-19.1%
Q3 FY2020CQ1 2020Mar 31, 2020$2.31M-36.7%
Q2 FY2020CQ4 2019Dec 31, 2019$2.34M+7.5%
Q1 FY2020CQ3 2019Sep 30, 2019$2.61M+17.8%
Q4 FY2019CQ2 2019Jun 30, 2019$2.57M+14.6%
Q1 FY2019CQ3 2018Dec 31, 2018$3.65M+56.9%
Q4 FY2018CQ2 2018Jun 30, 2018$2.18M-8.0%
Q3 FY2018CQ1 2018Mar 31, 2018$2.22M-9.7%
Q2 FY2018CQ4 2017Dec 31, 2017$2.25M-9.4%
Q1 FY2018CQ3 2017Sep 30, 2017$2.32M-8.5%
Q4 FY2017CQ2 2017Jun 30, 2017$2.36M-13.1%
Q3 FY2017CQ1 2017Mar 31, 2017$2.45M–
Q2 FY2017CQ4 2016Dec 31, 2016$2.48M–
Q1 FY2017CQ3 2016Sep 30, 2016$2.54M–
Q4 FY2016CQ2 2016Jun 30, 2016$2.72M–

More BioVie figures

See a number that looks wrong?